Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds were identified using a virtual screening approach.

A slew of recalled OTC eye drops during the past 2 years has diminished patient trust, but optometrists are equipped to restore it.

AI Optics, a biotech startup backed by NYU Langone and raising in stealth, announced clearance this week from the Food and ...